- CELG has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $318.2 million.
- CELG has traded 20,737 shares today.
- CELG is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in CELG with the Ticky from Trade-Ideas. See the FREE profile for CELG NOW at Trade-Ideas More details on CELG: Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. CELG has a PE ratio of 51.1. Currently there are 17 analysts that rate Celgene a buy, no analysts rate it a sell, and 4 rate it a hold. The average volume for Celgene has been 4.6 million shares per day over the past 30 days. Celgene has a market cap of $70.7 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.10 and a short float of 1.6% with 3.77 days to cover. Shares are up 4.7% year-to-date as of the close of trading on Thursday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.